Ronald S Go MD

Hematologic Oncology

Professor, Internal Medicine, Mayo Med Sch

200 1st St SWRochester, MN 55905
Phone+1 507-284-2511

Dr. Go is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Go's full profile Already have an account?

Summary

Dr. Ronald Go is an experienced hematologist located in Rochester, MN, specializing in classical hematology and histiocytosis. His clinical and research interests include autoimmune hemolytic anemia, Erdheim-Chester disease, immune thrombocytopenia, Langerhans cell histiocytosis, Rosai-Dorfman disease, and thrombotic microangiopathy. He completed his medical education at the University of Santo Tomas and pursued a residency in Internal Medicine at Baylor College of Medicine, followed by a fellowship in Hematology and Medical Oncology at Mayo Clinic College of Medicine and Science. Having previously worked as a community hematologist at Gundersen Lutheran Medical Center in La Crosse, Wisconsin, Dr. Go currently serves as the chair of classical hematology at Mayo Clinic, Rochester, Minnesota and a professor at the Mayo Clinic College of Medicine.

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1996 - 2000
Baylor College of MedicineResidency, Internal Medicine, 1993 - 1996
University of Santo TomasClass of 1991

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

AZ State Medical License 1998 - Present
MN State Medical License 2010 - 2027
IA State Medical License 2010 - 2014
WI State Medical License 2000 - 2013
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Centricity Patient Online, GE Healthcare, 2012-2017
CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2012-2017
CMS Meaningful Use Stage 2 Certification Mayo Clinic Electronic Notes, Mayo Clinic, 2012-2017

Clinical Trials

PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma Start of enrollment: 2004 Jan 13
COMPLETED
PHASE2
Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
COMPLETED
PHASE2
Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)
TERMINATED

Publications & Presentations

PubMed

Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents.
Saubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, Susan M Geyer, Ali Alsugair
American Journal of Hematology. 2026-09-01
Patterns of Progression and Clinical Outcomes After First Progression in Patients With Primary Plasma Cell Leukemia.
Daniel G Packard, Shaji K Kumar, Angela Dispenzieri, Prashant Kapoor, Guneet Janda
American Journal of Hematology. 2026-09-01
Absent Cyclin D1 Expression in Myeloid Sarcomas Distinguishes From Malignant Histiocytic Neoplasms: When Morphologic Ambiguity is Deceptive.
Alyssa M Lee, Neha Seth, Wayne Tam, Liuyan Jiang, Jithma P Abeykoon
The American Journal of Surgical Pathology. 2026-09-01

Journal Articles

Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple Myeloma
S Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of Relapse
Angela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature
Primary Systemic Amyloidosis in Patients with Waldenström Macroglobulinemia
Angela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature

Abstracts/Posters

Molecular Alterations in Adult Histiocytic Neoplasms
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
A Novel Approach to Risk Stratification in Multiple Myeloma Using ISS Stage and FISH
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Clinical Features and Outcomes of Unifocal Adult Langerhans Cell Histiocytosis
Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Monoclonal Gammopathy of Undetermined Significance (MGUS): Indications for Pre-Diagnostic Testing, Subsequent Diagnoses, and Follow-up Practice
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Association between Treatment Facility Volume and Mortality of Patients with Hodgkin Lymphoma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Long-Term Survivorship with Active Multiple Myeloma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Lab Medicine Edition | CBC: White Blood Cell Count (WBC) (Leukocytosis, Leukopenia)May 2nd, 2024
Expert Care, Teamwork Lead to Tailored Treatment for Alexa’s Rare CancerJanuary 10th, 2020
Clinical Challenges: Secondary ITPDecember 5th, 2018